Background {#Sec1}
==========

Acute respiratory distress syndrome (ARDS) is a severe condition that affects around 1 in 10,000 people every year with the mortality rate of 40--50 % \[[@CR1], [@CR2]\]. Mechanical ventilation (MV), involving the use of mechanical force to offload respiratory muscles of their work, is a fundamental component of treatment in the intensive care unit (ICU) for patients with ARDS. However, a problematic issue associated with MV is that it exposes patients' lungs to potentially destructive energy applied by the ventilator \[[@CR3]\]. Consequently, MV can induce lung injury and can increase the risk of non-pulmonary organ injury/failure, which further adds to morbidity and mortality for ARDS patients \[[@CR4]\].

A number of studies have shown that lowering the tidal volume (*V*~T~) can improve mortality rates in ARDS patients. Hickling et al. \[[@CR5]\] reported a 60 % decrease in the expected mortality rate among patients with ARDS by lowering *V*~T~. In another trial, Amato et al. \[[@CR6]\] investigated changing conventional *V*~T~ (12 ml/kg of predicted body weight, PBW) to low *V*~T~ and reported a 46 % reduction in mortality. This benefit was also confirmed in the ARDS Network study with mortality decreased by 22 % in the low tidal volume intervention group \[[@CR7]\]. However, reducing *V*~T~ by itself also leads to worsened partial pressures of arterial oxygen (PaO~2~) and carbon dioxide (PaCO~2~) and arterial pH \[[@CR8]\].

An alternative approach to achieve more protective ventilation is high-frequency oscillatory ventilation (HFOV) \[[@CR9]\]. In this approach, patients' lungs are not allowed to exhale fully (keeping them partially inflated, which maintains oxygenation), while CO~2~ is cleared by moving small volumes of gas in and out of the respiratory system at 3 to 15 Hz (180 to 900 b/min). This process has the potential to minimise the repeated opening and collapsing of lung units that can cause secondary lung damage during mechanical ventilation \[[@CR10]\]. Although HFOV is now a widely used lung-protective strategy in the treatment of neonatal and paediatric acute lung injury \[[@CR11]\], it cannot be implemented on conventional ventilators, and clinical studies have so far failed to show a significant effect on mortality in adult patients undergoing mechanical ventilation for ARDS \[[@CR12], [@CR13]\].

A number of previous studies have also investigated the potential of moderately high-frequency ventilation using standard ventilators \[[@CR14], [@CR15]\]. In this approach, respiratory rates (RRs) applied are beyond the limits of traditional mechanical ventilation but below those used in HFOV. A recent prospective study using porcine models (*N* = 8) in which ARDS was induced by pulmonary lavage and injurious ventilation \[[@CR16]\] supported the potential of moderately high-frequency ventilation to allow safe reductions in *V*~T~ and airway pressures while maintaining stable PaCO~2~ levels.

In this study, we explore whether the application of a similar approach using a high-fidelity computational simulator tuned to a number of human ARDS patient datasets confirms or refutes the results of this previous animal study. We also investigate a number of different approaches for practically implementing moderately high-frequency ventilation, by considering alternative algorithms for maintaining PaCO~2~ and reducing alveolar strain.

Methods {#Sec2}
=======

Computational simulator {#Sec3}
-----------------------

The computational simulator used in this study is a multi-compartmental computational model that uses an iterative, time-sliced, arithmetic technique to simulate integrated respiratory and cardiovascular pathophysiological scenarios \[[@CR17]--[@CR19]\]. The core models in the simulator have been designed to represent a dynamic in vivo cardiovascular-pulmonary state using a set of mass-conserving equations based on well-established physiological principles. The model simulates a lung comprising conducting airways and 100 alveolar compartments, with each compartment having a corresponding set of parameters accounting for stiffness, threshold opening pressures (TOPs) and extrinsic pressures as well as airway and peri-alveolar vascular resistances. The mathematical principles and equations on which the simulator is based have been detailed in previous studies \[[@CR20]--[@CR22]\], which have also validated the simulator's ability to represent the pulmonary disease states of individual patients with chronic obstructive pulmonary disease and ARDS. A detailed description of the principles and mathematical equations underlying the computational model implemented in our simulator is provided in Additional file [1](#MOESM1){ref-type="media"}.

Model matching to ARDS patient data {#Sec4}
-----------------------------------

The model was configured to match data from individual ARDS patients reported by Nirmalan and colleagues \[[@CR23]\], which listed arterial and mixed venous blood gas values and cardiac output measurements taken from patients treated for ARDS. The problem of matching the model's outputs to the patient data reported in \[[@CR23]\] was formulated as an optimisation problem, where the difference between the simulated model outputs and the data is measured by a cost function. Internal model parameters are then varied by a numerical optimisation algorithm \[[@CR24]\] in order to minimise this cost function. The cost function that captures the matching error between the model and the data is defined as:$$\documentclass[12pt]{minimal}
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where *E*~T~ is the total residual error representing the matching accuracy and $\documentclass[12pt]{minimal}
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                \begin{document}$$ {E}_i=\frac{x_i-{x}_{id}}{x_{id}} $$\end{document}$ is the error for output *i*, *x*~*i*~ is the value of output *i* returned by the simulation and *x*~*id*~ is the value of the data for that output. The model parameters for each compartment *i* used for the matching include threshold opening pressure TOP~*i*~, stiffness coefficient *S*~*i*~ and extrinsic pressure *P*~ext,*i*~, meaning that a total of 300 model parameters are considered for 100 compartments in the simulator. During the matching process, these parameters are allowed to vary continuously between physiologically realistic upper and lower bounds as defined in Table [1](#Tab1){ref-type="table"}.Table 1Nominal values and allowable ranges for the model parametersParametersNominal valueVariation rangesTOP~*i*~ (cmH~2~O)30(5, 60)Stiffness coefficient *S* ~*i*~ (cmH~2~O/ml^2^)0.05(0.005, 0.5)Extrinsic pressure *P* ~ext,*i*~ (cmH~2~O)28.8(−20, 28.8)

Global optimisation algorithms can then be used to find model parameter values that minimise the value of *E*~T~, i.e. minimise the difference between the model outputs and the data. The procedure is illustrated in detail in Additional file [1](#MOESM1){ref-type="media"}---in each iteration, a set of parameter combinations are sent to the simulator and the outputs from the simulator are evaluated by the optimisation algorithm which then generates the updated parameter values for the next iteration until the condition to get a best matching is found. In this study, we employed an advanced global optimisation algorithm known as a g*enetic algorithm*, a general-purpose, stochastic search and optimisation procedure, based on genetic and evolutionary principles \[[@CR24]\]. Full details of the particular optimisation algorithm used in this study and how it was implemented with the model are also provided in Additional file [1](#MOESM1){ref-type="media"}.

Strategies for implementing moderately high-frequency ventilation {#Sec5}
-----------------------------------------------------------------

After matching the model to the patient datasets, three different ventilation strategies were applied and evaluated separately on each of the virtual patients. The primary objective of the ventilation strategies was always to maintain a constant PaCO~2~ while increasing RR and reducing *V*~T~.

### Strategy 1 {#Sec6}

The first two strategies attempt to calculate appropriate ventilator settings based on simple physiological equations that are widely used in clinical practice. To maintain PaCO~2~, patients are expected to have constant alveolar minute ventilation, which can be calculated using the following equation \[[@CR25]\]:$$\documentclass[12pt]{minimal}
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In Eq. ([2](#Equ2){ref-type=""}), *M*~V~alv is the alveolar minute ventilation, RR is the respiratory rate, *V*~T~ is the tidal volume and *V*~D~anat is the anatomical dead space. To investigate the effect of higher frequency ventilation, the ventilator rate RR for each of the virtual patients is increased from 16 to 48 b/min in steps of 8 b/min, with each step lasting for 20 min. At each step, the corresponding *V*~T~ is reduced according to Eq. ([2](#Equ2){ref-type=""}) above, so as to maintain constant alveolar minute ventilation. *V*~D~anat can be estimated based on the ideal body weight \[[@CR26]\]; in this study, we used a value of 160 ml, based on an adult patient with ideal body weight of 70 kg.

### Strategy 2 {#Sec7}

Here, as well as keeping alveolar minute ventilation constant using Eq. ([2](#Equ2){ref-type=""}), the inspiratory flow is also kept constant (this corresponds to the strategy implemented in \[[@CR16]\]). This can be achieved in our simulator by using the equation \[[@CR25]\]:$$\documentclass[12pt]{minimal}
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where *F*~insp~ is the inspiratory flow into the lung from the ventilator and DC is the duty cycle (inspiratory time divided by total cycle time). From Eq. (3), by varying DC, *F*~insp~ can be manipulated since *V*~T~ is already determined by Eq. ([2](#Equ2){ref-type=""}). Thus, the difference between strategies 1 and 2 is that DC is set as constant for the first, while for the latter, DC is varied to achieve constant inspiratory flow.

### Strategy 3 {#Sec8}

An alternative approach to computing changes in ventilator settings based on simple physiological equations is to exploit the computational simulator directly. In this approach, we use numerical optimisation to calculate the value of *V*~T~ at each increment of RR that will minimise the change in the value of PaCO~2~. For each value of RR from 16 to 48 b/min at each step, the corresponding values of *V*~T~ (denoted by *p*~1~, *p*~2~,..., *p*~5~) are selected by an optimisation algorithm between a lower bound of 2.5 ml/kg and an upper bound of 8 ml/kg. A cost function is defined as the difference between the model-generated values and the initial value of PaCO~2~. During the optimisation process, the values of *p*~*i*~ are considered as optimisation variables that are systematically varied within the bounded space until the values that minimise the cost function are found. The process is then repeated for all three patient models.

Results {#Sec9}
=======

Matching the simulator to ARDS patient datasets {#Sec10}
-----------------------------------------------

To configure the virtual ARDS patients, three sets of patient data from Nirmalan's study \[[@CR23]\] were used, which are classified as mild (patient A, partial pressure of arterial oxygen/fraction of inspired oxygen (PaO~2~/FIO~2~) ratio 253.9 mmHg), moderate (patient B, PaO~2~/FIO~2~ ratio 166.3 mmHg) and severe (patient C, PaO~2~/FIO~2~ ratio 55.6 mmHg) according to the ARDS Berlin definition \[[@CR27]\]. The initial *V*~T~ was set at 8 ml/kg (assuming ideal body weight of 70 kg), and RR was set to 12.5 b/min for all three patients. The cardiac output (CO), FiO~2~ and haemoglobin (Hb) were configured using the data reported in the reference. Pulmonary vascular resistance (PVR) and compliance used for the model are also reported in Table [2](#Tab2){ref-type="table"}. The model outputs to be matched included PaO~2~, partial pressure of oxygen in mixed venous blood (PvO~2~), partial pressure of carbon dioxide in the venous blood (PvCO~2~) and pulmonary shunt fraction. The initial value of PaCO~2~ was produced by the model at the matched state. An optimisation algorithm was run to minimise the difference between model outputs and the data based on Eq. (1), until a predefined termination criterion was reached. The model-fitting results are reported in Table [2](#Tab2){ref-type="table"}; this shows that close matches to each of the three patient datasets were achieved by the simulator.Table 2Model fitting for three ARDS patientsPatient APatient BPatient CCO (l/min)13.010.13.9FIO~2~0.811Hb (g/l)1127998PVR (dyn s cm^−5^)152.0152.1151.9*C* ~dyn~ (ml/mbar)373133DC (ratio)0.330.330.33RR (b/min)12.512.512.5DataModelDataModelDataModelPaO~2~ (mmHg)201203.1165.75166.2956.3255.59PvO~2~ (mmHg)45.8347.684241.5124.8325.66PvCO~2~ (mmHg)46.7343.3443.543.6139.339.79Shunt (% of CO)30.030.833.534.734.735.21

Effectiveness of the three ventilation strategies {#Sec11}
-------------------------------------------------

The ventilation settings used for each strategy are reported in Table [3](#Tab3){ref-type="table"} and are also shown in Fig. [1](#Fig1){ref-type="fig"}. For strategies 1 and 2, the same settings for *V*~T~ are applied to each patient; see Fig. [1](#Fig1){ref-type="fig"}a. For strategy 3, the optimal values of *V*~T~ are computed for each patient using numerical optimisation; see Fig. [1](#Fig1){ref-type="fig"}b. Figure [1](#Fig1){ref-type="fig"}c shows the same pattern of RR applied for all strategies, and the variations of DC are shown in Fig. [1](#Fig1){ref-type="fig"}d. The corresponding changes of the P/F ratio, PaCO~2~, peak alveolar pressure (*P*~alv~, calculated from the 25 % of alveoli with highest pressures), dynamic compliance (*C*~dyn~) and the volume of the lung at the end of inhalation and exhalation (*V*~lung~) for each patient are shown in Figs. [2](#Fig2){ref-type="fig"}, [3](#Fig3){ref-type="fig"} and [4](#Fig4){ref-type="fig"}. For all patients, strategies 1 and 2 led to significant changes in PaCO~2~, whereas strategy 3 kept the value of PaCO~2~ almost constant for all combinations of *V*~T~ and RR. The changes in PaCO~2~ observed for strategies 1 and 2 are accompanied by large increases in the P/F ratio (due to alveolar recruitment arising from increases in *P*~alv~)---only strategy 3 showed a consistent reduction in *P*~alv~ as RR increased, i.e. only strategy 3 implemented a more *protective* ventilation strategy. The potential of moderately high-frequency ventilation to deliver more protective ventilation is further supported by Fig. [5](#Fig5){ref-type="fig"}, where dynamic strain (*V*~T~/FRC, ratio) can be seen to decrease most significantly in all three simulated patients as RR is increased using strategy 3.Table 3Ventilation settings for strategies 1 and 2RR (b/min)1624324048*V* ~T~ (ml)497.5385328.75295272.5*V* ~D~anat (ml)160160160160160*M* ~V~alv (ml/min)54005400540054005400DC (ratio) (strategy 1)0.330.330.330.330.33DC (ratio) (strategy 2)0.400.460.520.580.65*F* ~insp~ (ml/s) (strategy 1)404.04466.67531.31595.96660.61*F* ~insp~ (ml/s) (strategy 2)337337337337337Fig. 1Mechanical ventilator settings for each ventilation strategy. **a** *V* ~T~ for strategies 1 and 2. **b** *V* ~T~ for strategy 3. **c** RR for all strategies. **d** DC for each strategyFig. 2Model outputs for patient A under different ventilation strategiesFig. 3Model outputs for patient B under different ventilation strategiesFig. 4Model outputs for patient C under different ventilation strategiesFig. 5Dynamic alveolar strain (*V* ~T~/FRC) for each patient as RR increased under the different ventilation strategies

Discussion {#Sec12}
==========

Why do strategies 1 and 2 result in large changes in PaCO~2~ when they are predicated on maintaining constant alveolar minute ventilation and inspiratory flow? The answer is provided by Fig. [6](#Fig6){ref-type="fig"}, which plots the relationship between the total dead space (physiological dead space, *V*~D~phys) calculated in the simulation model and *V*~T~ for each virtual patient. As shown, as RR increases, the value of *V*~D~phys is not constant, as assumed in Eqs. ([2](#Equ2){ref-type=""}) and ([3](#Equ3){ref-type=""}) using *V*~D~anat (on which strategies 1 and 2 are based), but is strongly proportional to *V*~T~. It may also be observed that the ratio *V*~D~phys/*V*~T~ is similar through the spectrum of ARDS severity. Interestingly, this relationship has previously been shown experimentally in the context of high-frequency ventilation \[[@CR28]\]. Thus, the simple formulae on which strategies 1 and 2 are based do not correctly compute the required changes in *V*~T~ and RR to keep alveolar minute ventilation constant with either constant or variable inspiratory flow.Fig. 6Relationship between *V* ~D~phys and *V* ~T~ for each patient using strategy 3

A test was performed using the model that calculated *V*~D~phys instead of *V*~D~anat during each step to estimate which *V*~T~ should be applied in the next change of RR to maintain *M*~V~alv based on Eq.([2](#Equ2){ref-type=""}). The simulation results for patient C using strategy 1 with the calculated *V*~D~phys are shown in Fig. [7](#Fig7){ref-type="fig"}. It can be seen that although PaCO~2~ was not constant, it remained within an acceptably narrow range, which is significantly improved compared with the results in Fig. [4](#Fig4){ref-type="fig"}. In practice, therefore, if a device could provide a measurement of *V*~D~phys in a sufficiently short time, our results indicate that PaCO~2~ could be well controlled using this approach.Fig. 7Model outputs for patient C using strategy 1 with calculated *V* ~D~phys

The benefits of a normal or only slightly elevated level of PaCO~2~ in critically ill patients are well recognised. It is, however, difficult and sometimes impossible to achieve this in a patient with ARDS without increasing the risk of alveolar injury. The concept of permissive hypercapnia is now an accepted management strategy for the critically ill lung. The rationale behind this approach is primarily to minimise lung strain, which could otherwise be worsened by strenuous ventilatory strategies aimed at keeping PaCO~2~ within normal physiological limits. However, in a very severe lung disease, the rise in PaCO~2~ is sometimes difficult to control using conventional protective ventilation strategies. Extracorporeal CO~2~ removal devices have been used in clinical practice for a few years now, but they bring potentially dangerous side effects \[[@CR29]\]. The efficacy of these devices in allowing ultra-protective ventilation strategies, with tidal volumes and pressures comparable to those used in our model simulation, is being tested at present in the SUPERNOVA trial \[[@CR30]\].

The benefit of the moderately high-frequency ventilation strategies we tested in this model is that they allow the maintenance of a normal level of PaCO~2~ while seeming to have the potential for decreasing the risk of lung injury and, in some cases, while recruiting the lung. The problem of improving lung protection in ARDS is obviously an extremely complex and multifaceted one and involves consideration of multiple factors beyond mechanical pressure limits. Nonetheless, our results indicate that moderately high-frequency ventilation could represent a beneficial ventilation strategy in ARDS patients with reduced respiratory system compliance. An interesting question for future investigation is to determine the potential for reducing driving pressure using this strategy, since a recent retrospective analysis of nine randomised trials indicated that driving pressure was the variable most strongly associated with survival \[[@CR31]\]. Our study has a number of limitations, principally the small number of "virtual" patients evaluated and the lack of prospective validation in clinical trials. We note, however, that our findings confirm and help to explain the results of a previous study using animal models that investigated very similar changes in ventilator settings \[[@CR16]\].

Conclusions {#Sec13}
===========

By using a high-fidelity computational simulator, a more protective ventilation strategy consisting of progressive reductions in *V*~T~ with simultaneous increases in RR could be developed for a number of different virtual ARDS patients, covering the spectrum from mild to severe presentations of the disease. This strategy allowed changes in PaCO~2~ to be kept within an acceptable range in each case, thus confirming the results reported on a cohort of porcine models in \[[@CR16]\], which showed that moderately high-frequency ventilation could allow safe reductions in the levels of *V*~T~. Attempts to compute appropriate values for the decrements in *V*~T~ required to compensate for increments in RR using simple mathematical formulae were not successful, due to the fact that dead space varies significantly with changes in *V*~T~. Our results demonstrate the importance of using advanced simulation models in order to correctly represent the complex dynamics of ventilator-lung interactions and highlight the potential of such models to refine or replace animal trials in this area.

Additional file {#Sec14}
===============

Additional file 1:**Simulation model description and optimisation algorithm description.**
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